1Norgren L, Hiatt WR,Dormandy JA, et al. Inter society consensus for the management of peripheral arterial disease (TASCⅡ) [J]. J Vasc Surg, 2007; 45 Suppl S: S5-S67.
2Met R, Van Lienden KP, Koelemay MJ, et al. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review [J]. Cardiovasc Intervent Radiol, 2008, 31 (4): 687-697.
3Ruckert RI, Tsilimparis N, Lobenstein B, et al. Midterm results of a precuffed expanded polytetrafluoroethylene graft for above knee femoropopliteal bypass in a multicenter study [J]. J Vasc Surg, 2009; 49(5): 1203 -1209.
4McQuade K, Gable D, Hohman S, et al. Randomized comparison of ePTgE/nitinol self expanding stem graft vs pros thetic femoral popliteal bypass in the treatment of superficial femoral artery occlusive disease [J]. J Vasc Surg, 2009; 49 (1): 109- 116.
5Faglia E, Cleriei G, Clerissi J, et al. Long-term prognosis of diabetic patients with critical limb ischemia: a populationbased cohort study [J]. Diabetes Care, 2009; 32(5): 822- 827.
6Graziani L, Silvestro A, Bertone V, et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease [J]. Nephrol Dial Transplant, 2007; 22(4): 1144 -1149.
8Faries PL, Arota S, Pomposelli FB Jr, et al. The use of arm vein in lower extremity revascularization: results of 520 procedures performed in eight years [J]. J Vasc Surg, 2000, 31 (1 Pt 1): 50- 59.
9Halloran BG, Lilly MP, Cohn EJ, et al. Tibial bypass using complex autologous conduit: patency and limb salvage [J]. Ann Vasc Surg, 2001, 15(6): 634-643.
10Rabellino M, Zander T, Baldi S, et al. Clinical follow-up in endovaseular treatment for TASC C-D lesions in femoro-popliteal segment [J]. Catheter Cardiovasc Interv, 2009; 73 (5): 701 -705.
